H J Heidebrecht

693 total citations
12 papers, 603 citations indexed

About

H J Heidebrecht is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, H J Heidebrecht has authored 12 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 5 papers in Immunology. Recurrent topics in H J Heidebrecht's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Mechanisms and Therapy (3 papers) and Peptidase Inhibition and Analysis (3 papers). H J Heidebrecht is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Mechanisms and Therapy (3 papers) and Peptidase Inhibition and Analysis (3 papers). H J Heidebrecht collaborates with scholars based in Germany and Sweden. H J Heidebrecht's co-authors include Hans Wacker, Reza Parwaresch, Friedrich Buck, Karen M. Haas, H. J. Radzun, Joerg Steinmann, Raimund Sprenger, Hans Kreipe, Markus Tiemann and M. L. Hansmann and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and International Journal of Cancer.

In The Last Decade

H J Heidebrecht

12 papers receiving 591 citations

Peers

Countries citing papers authored by H J Heidebrecht

Since Specialization

Citations

This map shows the geographic impact of H J Heidebrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H J Heidebrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H J Heidebrecht more than expected).

Fields of papers citing papers by H J Heidebrecht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H J Heidebrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H J Heidebrecht. The network helps show where H J Heidebrecht may publish in the future.

Co-authorship network of co-authors of H J Heidebrecht

This figure shows the co-authorship network connecting the top 25 collaborators of H J Heidebrecht. A scholar is included among the top collaborators of H J Heidebrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H J Heidebrecht. H J Heidebrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Lysyl oxidase like‐4 monoclonal antibody demonstrates therapeutic effect against head and neck squamous cell carcinoma cells and xenografts 2016 ·International Journal of Cancer ·Tibor Görögh, Elgar Susanne Quabius, H J Heidebrecht, (unknown), (unknown), Jochen Haag, Petra Ambrosch, Markus Hoffmann	11
2	Immunoenzymatic detection of the new proliferation associated protein p100 by means of a cellular ELISA: specific detection of cells in cell cycle phases S, G2 and M 1999 ·Journal of Immunological Methods ·(unknown), P. Rudolph, Christian Dworeck, (unknown), H J Heidebrecht, Joerg Steinmann, J. Neppert, Reza Parwaresch	11
3	Immunologic Proliferation Marker Ki-S2 as Prognostic Indicator for Lymph Node-Negative Breast Cancer 1999 ·JNCI Journal of the National Cancer Institute ·P. Rudolph, Per Alm, H J Heidebrecht, H. Bolte, (unknown), Bo Baldetorp, Mårten Fernö, Håkan Olsson, Reza Parwaresch	63
4	The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigen. 1998 ·PubMed ·(unknown), Ruth Knüchel, Elmar Endl, H J Heidebrecht, (unknown), (unknown)	25
5	Sinus-lining cells of the lymph nodes recognized as a dendritic cell type by the new monoclonal antibody Ki-M9. 1997 ·PubMed ·Hans Wacker, (unknown), H J Heidebrecht, Reza Parwaresch	13
6	p100: A Novel Proliferation-Associated Nuclear Protein Specifically Restricted to Cell Cycle Phases S, G2 , and M 1997 ·Blood ·H J Heidebrecht, Friedrich Buck, Joerg Steinmann, Raimund Sprenger, Hans Wacker, Reza Parwaresch	24
7	p100: A Novel Proliferation-Associated Nuclear Protein Specifically Restricted to Cell Cycle Phases S, G2 , and M 1997 ·Blood ·H J Heidebrecht, Friedrich Buck, Joerg Steinmann, Raimund Sprenger, Hans Wacker, Reza Parwaresch	94
8	Monoclonal antibodies Ki‐S3 and Ki‐S5 yield new data on the ‘Ki‐67’proteins 1996 ·Cell Proliferation ·H J Heidebrecht, Friedrich Buck, Karen M. Haas, Hans Wacker, Reza Parwaresch	80
9	Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA 1994 ·Journal of Cancer Research and Clinical Oncology ·Manfred Dietel, (unknown), (unknown), (unknown), Birgit M. Schaefer, Andreas Bunge, H J Heidebrecht, André Seidel	16
10	Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. 1993 ·PubMed ·Hans Kreipe, Hans Wacker, H J Heidebrecht, Karen M. Haas, (unknown), Markus Tiemann, Reza Parwaresch	64
11	A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1. 1993 ·PubMed ·Hans Kreipe, H J Heidebrecht, Steinbjørn Hansen, (unknown), Manfred Kubbies, Hans Wacker, Markus Tiemann, H. J. Radzun, Reza Parwaresch	67
12	Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1P. 1991 ·PubMed ·H. J. Radzun, M. L. Hansmann, H J Heidebrecht, (unknown), Hans Wacker, Hans Kreipe, (unknown), Carmen Hernández, C Kuhn, M R Parwaresch	135

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact